CN102205099B - Chinese medicinal composition for treating ankylosing spondylitis - Google Patents

Chinese medicinal composition for treating ankylosing spondylitis Download PDF

Info

Publication number
CN102205099B
CN102205099B CN2011101187079A CN201110118707A CN102205099B CN 102205099 B CN102205099 B CN 102205099B CN 2011101187079 A CN2011101187079 A CN 2011101187079A CN 201110118707 A CN201110118707 A CN 201110118707A CN 102205099 B CN102205099 B CN 102205099B
Authority
CN
China
Prior art keywords
parts
ankylosing spondylitis
herba
chinese medicine
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2011101187079A
Other languages
Chinese (zh)
Other versions
CN102205099A (en
Inventor
刘云昌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011101187079A priority Critical patent/CN102205099B/en
Publication of CN102205099A publication Critical patent/CN102205099A/en
Application granted granted Critical
Publication of CN102205099B publication Critical patent/CN102205099B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a Chinese medicinal composition for treating ankylosing spondylitis, which is prepared from the following materials: centipede, scorpion, ground beeltle, garter snake, musk, white mustard seed, ephedra, deerhorn glue, white pepper, prepared rehmannia root, cassia bark, blast-fried ginger, safranine, Chinese caterpillar fungus, honeysuckle flower, common clubmoss herb and garden balsam stem. The Chinese medicinal composition for treating the ankylosing spondylitis does not have toxic or side effects on human bodies and has quick response, the ankylosing spondylitis is difficult to relapse after healing, and the effective rate is 100 percent.

Description

A kind of Chinese medicine composition of treating ankylosing spondylitis
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of Chinese medicine composition that is used to treat ankylosing spondylitis.
Background technology
Ring wind is claimed in ankylosing spondylitis again, and medical circle does not have satisfied understanding to this disease at present.Main multiple adolescence, the initial stage shows as down flank pain, at first corrodes ability bone joint because of ankylosing spondylitis, gradually to vertical spread, makes each articular ligament calcification of vertebra, and the X line shows that intervertebral space disappears, and vertebra is ring appearance and becomes; Early stage being difficult for finds that late period, back pain increased the weight of, can not sitting, form serious bow-backedly at last, and stiffness of the neck can not be upright, and front and back spinal column movable function is limited.
Doctor trained in Western medicine does not have specific medicament and method as yet at present.Under the situation of general early stage employing indometacin analgesic and damp and hot external application controlling symptoms, correct and prevent odd-shaped functional exercise as early as possible.Available in case of necessity adrenocortical steroid.Have lopsided tetanic person late period, implement orthomorphia in the static back of pathological changes, to improve function.Rapidly pain relieving of radiotherapy, but can not prevent the development of pathological changes, and have malignant tumor such as the leukemia of bringing out or fibrosarcoma maybe, so clinical few usefulness.The patient generally selects traditional Chinese medical herbal treatment.Though ankylosing spondylitis is the Western medicine diagnose noun, motherland's medical science (being the traditional Chinese medical science) early has understanding to it, and is historical remote.Description to primary disease is shown in the B.C. 475-221 the Warring States Period the earliest, according to Clinical symptoms, pathogenic characteristic and the state of an illness evolution process of ankylosing spondylitis, it is belonged to it " rheumatism involving the bone " " BI-syndrome involved the kidney " category of arthromyodynia, and it has the characteristics of " feeling again in heresy; the interior house in kidney " again, says like Huangdi's Internal Classics: " rheumatism involving the bone is endlessly felt in heresy; the interior house in kidney again ", add: and " BI-syndrome involved the kidney person, the people are with the generation heel; hunchback ", the meaning is to replace biped with buttocks, can not walk; Because of far seeming head after rachiocamposis or the hunchback, the deformity of having described ankylosing spondylitis spinal column, marrow joint changes comparison image, explains that poker spine can not bend and stretch and cause the difficulty that sits up.Recent famous Jiao physician establishes one's virtue and proposes ankylosing spondylitis is referred to as " severe hunch-back ", and lackey refers to rachiocamposis, the disease that severe hunch-back refers to be seriously ill, rachiocamposis, the back of the body are bowed.Say like Huangdi's Internal Classics: " cloudy gas person, open entire must not, cold is from it, just gives birth to severe hunch-back ", Wang Bingzhu says " health stoops, can not be upright, lackey, rachiocamposis ".The traditional Chinese medical science is thought to compose deficiency because the patient examines in a word, or owing to take good care of oneself accidentally, chamber does not save; Having a liking for drink does not have joint and terrified, disgruntled, imbalance after being ill etc., causes QI and blood, deficiency of both the liver and kidney, invades muscles and bones in the wind-cold damp pathogen; Numbness resistance muscle arteries and veins, QI and blood is obstructed, and silt expectorant stagnates; Muscles and bones mistake is supported, and joint muscles and bones is closed and stagnated and a primary disease.Giving consideration to both the incidental and fundamental is answered in the treatment of primary disease, and strengthening vital QI to eliminate pathogenic factors chases after wind and touches wetly, takes whole body into account, makes that Liver and kidney foot, QI and blood fill, rheumatism is removed, cold coagulation disappears, muscles and bones be good for, numbness is only ached.So the author can effectively control ankylosing spondylitis from intending Zaocys Wheeling soup, softening calcified tissue, eliminate pain, combined function is taken exercise, and obtains better curative effect.
Adopt all for this type of sick doctor trained in Western medicine that ibuprofen, antiinflammatory are painful etc. to be added the hormone therapy antiinflammatory and relieve the pain; Side effect is very big, and its cure rate is extremely low, and can only take stopgap measures and can not effect a permanent cure; And in human body, be prone to form residual; Influence the healthy of people and can cause other diseases, and cost is high, causes very big economically burden to the people.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition that is used to treat ankylosing spondylitis.
In order to realize the object of the invention; The present invention provides a kind of Chinese medicine composition of treating ankylosing spondylitis, and it is to be processed by following materials by weight: Scolopendra 3-6 part, Scorpio 10-20 part, Eupolyphaga Seu Steleophaga 15-25 part, Zaocys 1-3 part, Moschus 0.5-1 part, Semen Sinapis Albae 6-12 part, Herba Ephedrae 5-10 part, Colla cornus cervi 8-12 part, Radix orixae japonicae 8-15 part, Radix Rehmanniae Preparata 1-20 part, Cortex Cinnamomi 3-6 part, Rhizoma Zingiberis Preparatum 3-6 part, Stigma Croci 1-3 part, Cordyceps 2-6 part, Flos Lonicerae 10-15 part, Herba Lycopodii 10-15 part and Herba speranskiae tuberculatae 10-15 part.
Preferably, the Chinese medicine composition of described treatment ankylosing spondylitis is to be processed by following materials by weight: 12 parts of 5 parts of Scolopendras, 15 parts of Scorpios, 20 parts of Eupolyphaga Seu Steleophagas, 2 parts of Zaocyss, 1 part in Moschus, 7 parts of Semen Sinapis Albaes, 8 parts in Herba Ephedrae, 10 parts of Colla cornus cervis, 10 parts of Radix orixae japonicaes, 10 parts of Radix Rehmanniae Preparata, 5 parts of Cortex Cinnamomis, 5 parts of Rhizoma Zingiberis Preparatums, 2 parts of Stigma Crocis, 5 parts of Cordyceps, 13 parts of Flos Loniceraes, 12 parts of Herba Lycopodiis and Herba speranskiae tuberculataes.
Preferably, said Chinese medicine composition can be made into medicated wine.
The inventor finds unexpectedly in development process that on forefathers' basis the medicine that makes in the processes has better curative effect: in the preparation, will be good for the bulls capitellum amputate empty subsequent use.Above-mentioned medical material is concocted with strong yellow wine, stirred with Medulla Bovis seu Bubali behind the porphyrize and fill in the Medulla Bovis seu Bubali intracavity and compress, seal with Kuwaki stopper Semen Fagopyri Esculenti batter.Burn the thin duration and degree of heating of seeing with the baking of Ramulus Mori slow fire.Treat the bone crack Bai Yanhou of emerging, hear flavor and judge the duration and degree of heating.Strong yellow wine waters place, thigh crack, bone is washed open got it filled, and promptly steams the bone sweating medicine, and wine is taken after mixing with liquid.After taking medicine, can to 50 ℃ electromagnetism bed, have a rest heating, lid was by about 3 hours of diaphoresis, and Yongquan acupoint is perspired for good.In therapeutic process, taboo is prone to stimulating food half a year.On this basis, the inventor has carried out improving and having accomplished the present invention.
The Chinese medicine composition of treatment ankylosing spondylitis of the present invention is cured the back and is difficult for recurrence the human non-toxic side effect, and instant effect is used Drug therapy ankylosing spondylitis effective percentage 100% of the present invention.
The specific embodiment
Further specify the present invention through embodiment below.It should be understood that embodiments of the invention are to be used to explain the present invention rather than limitation of the present invention.The simple modifications that essence according to the present invention is carried out the present invention all belongs to the present invention and requires the scope protected.
The preparation of embodiment medicated wine
Take by weighing Scolopendra 50 grams, Scorpio 150 grams, Eupolyphaga Seu Steleophaga 200 grams, Zaocys 20 grams, Moschus 10 grams, Semen Sinapis Albae 70 grams, Herba Ephedrae 80 grams, Colla cornus cervi 100 grams, Radix orixae japonicae 100 grams, Radix Rehmanniae Preparata 100 grams, Cortex Cinnamomi 50 grams, Rhizoma Zingiberis Preparatum 50 grams, Stigma Croci 20 grams, Cordyceps 50 grams, Flos Lonicerae 130 grams, Herba Lycopodii 120 grams and Herba speranskiae tuberculatae 120 grams; Place strong yellow wine (available from your auspicious strong yellow brewery of Boxing County, Shandong; Alcoholic strength 20 (v/v)) in 1000 gram; Dipping filtered after January, must filtrate.
Experimental example
One, patient's data
Treat 30 examples, wherein male 15 examples, women 15 examples, the oldest 52 years old, minimum 30 years old, 41 years old mean age.The diagnostic criteria that the academic forum of national part provinces and cities' combination of Chinese and Western medicine rheumatism in 1985 is formulated.1. symptom wherein: with both sides sacroiliac joint, lower back repeatedly pain be main.2. sign: early, patient's spinal column activity in mid-term is limited in various degree, it is bow-backed fixing that tetanic property appears in the patients with terminal spinal column, and the thorax mobility reduces or disappears.3. lab testing: erythrocyte sedimentation rate speeds more, rheumatoid factor negative, and HLA-B27 is positive.The X ray examination: the typical case with ankylosing spondylitis and sacroiliitis changes.
Two, Therapeutic Method
Use the medicated wine for preparing among the embodiment to treat.Oral three times on the one, one time 20 gram.2 week was a course of treatment.
Three, efficacy assessment standard
1. clinical symptom disappearance promptly disappears through treatment pain, and movable function improves or recovers normal.2. each item laboratory indexes is reduced to normally.3. X-ray film shows does not have new lopsided development, and ostealleosis stops.4. morning deadlock<15min, recovering daily work is clinical cure.Above each item index all take a favorable turn and is clinical produce effects.Above each item index has two to transfer to clinical effective well.Treat 1~3 course of treatment, more than 4 indexs all do not have be improved as invalid.
Four, result
30 routine patients' therapeutic effect is produce effects,
Five, untoward reaction
In therapeutic process, carry out tracing observation for 30 routine patients, do not find tangible untoward reaction.

Claims (3)

1. Chinese medicine composition of treating ankylosing spondylitis; It is characterized in that it is to be processed by following materials by weight: Scolopendra 3-6 part, Scorpio 10-20 part, Eupolyphaga Seu Steleophaga 15-25 part, Zaocys 1-3 part, Moschus 0.5-1 part, Semen Sinapis Albae 6-12 part, Herba Ephedrae 5-10 part, Colla cornus cervi 8-12 part, Radix orixae japonicae 8-15 part, Radix Rehmanniae Preparata 1-20 part, Cortex Cinnamomi 3-6 part, Rhizoma Zingiberis Preparatum 3-6 part, Stigma Croci 1-3 part, Cordyceps 2-6 part, Flos Lonicerae 10-15 part, Herba Lycopodii 10-15 part and Herba speranskiae tuberculatae 10-15 part.
2. the Chinese medicine composition of treatment ankylosing spondylitis according to claim 1; It is characterized in that it is to be processed by following materials by weight: 12 parts of 5 parts of Scolopendras, 15 parts of Scorpios, 20 parts of Eupolyphaga Seu Steleophagas, 2 parts of Zaocyss, 1 part in Moschus, 7 parts of Semen Sinapis Albaes, 8 parts in Herba Ephedrae, 10 parts of Colla cornus cervis, 10 parts of Radix orixae japonicaes, 10 parts of Radix Rehmanniae Preparata, 5 parts of Cortex Cinnamomis, 5 parts of Rhizoma Zingiberis Preparatums, 2 parts of Stigma Crocis, 5 parts of Cordyceps, 13 parts of Flos Loniceraes, 12 parts of Herba Lycopodiis and Herba speranskiae tuberculataes.
3. the Chinese medicine composition of treatment ankylosing spondylitis according to claim 1 and 2 is characterized in that, said Chinese medicine composition is processed medicated wine.
CN2011101187079A 2011-05-10 2011-05-10 Chinese medicinal composition for treating ankylosing spondylitis Expired - Fee Related CN102205099B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011101187079A CN102205099B (en) 2011-05-10 2011-05-10 Chinese medicinal composition for treating ankylosing spondylitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011101187079A CN102205099B (en) 2011-05-10 2011-05-10 Chinese medicinal composition for treating ankylosing spondylitis

Publications (2)

Publication Number Publication Date
CN102205099A CN102205099A (en) 2011-10-05
CN102205099B true CN102205099B (en) 2012-07-04

Family

ID=44694341

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011101187079A Expired - Fee Related CN102205099B (en) 2011-05-10 2011-05-10 Chinese medicinal composition for treating ankylosing spondylitis

Country Status (1)

Country Link
CN (1) CN102205099B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103394069B (en) * 2013-08-21 2014-12-24 宋立学 Traditional Chinese medicine composition for treating ankylosing spondylitis and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1966042A (en) * 2006-09-22 2007-05-23 任景全 Externally applied ointment for treating hyperosteogeny and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1966042A (en) * 2006-09-22 2007-05-23 任景全 Externally applied ointment for treating hyperosteogeny and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王作民等.中药内服外敷治疗强直性脊椎炎.《中医外治杂志》.2004,第13卷(第06期),9. *

Also Published As

Publication number Publication date
CN102205099A (en) 2011-10-05

Similar Documents

Publication Publication Date Title
CN102743534A (en) Novel mud therapy product for emitting heat by being applied outside human body and application thereof
CN101361818B (en) Traditional Chinese medicine combination for treating shoulder-hand syndrome
CN102688410A (en) Chinese medicinal composition for treating chronic pelvic inflammation
CN103191382A (en) Medicine for treating Bi syndrome and preparation method thereof
CN101912536B (en) Medicinal composition for treating rheumatism and rheumatoid disease
CN104000993A (en) Pills with effects of strengthening bones and stretching muscles and tendons and preparation technology thereof
CN102205099B (en) Chinese medicinal composition for treating ankylosing spondylitis
CN102600272B (en) Traditional Chinese medicine for treatment of orthopedic disease
CN101912458B (en) Medicament for treating protrasion of the lumbar intervertebral disci
CN104288303A (en) Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases
CN103989968B (en) A kind of oral medication stenosis Chinese medicine composition
CN101347558A (en) Chinese medicine for treating rheumatism osteonosus
CN102600251B (en) Rheumatism-rehabilitating traditional Chinese formulation
CN103394069B (en) Traditional Chinese medicine composition for treating ankylosing spondylitis and preparation method thereof
CN105853902A (en) Plaster for treating lumbar disc herniation and preparation method thereof
CN102133380B (en) Medicament for treating cervical spondylosis
CN1246362A (en) Medicine for treating hyperosteogeny
CN101579395B (en) Traditional Chinese medicine for treating kidney weakness
CN110507796A (en) A kind of Chinese medicine preparation for treating a variety of diseases
CN102430066B (en) Sciatic nerve liquid
CN101518559B (en) Chinese medicinal preparation for treating bone disease
CN100551414C (en) A kind of Chinese herbal medicine for the treatment of ankylosing spondylitis
CN104644732B (en) A kind of Chinese medicine preparation for the treatment of deficiency of the liver and kindey type postmenopausal osteoporosis
CN101168035B (en) External-applied medicine for treating hyperosteogeny
CN104042703B (en) A kind of medicated wine being used for the treatment of rheumatic arthritis and its preparation method and application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120704

Termination date: 20180510

CF01 Termination of patent right due to non-payment of annual fee